Showing 851-860 of 1116 results for "".
- FDA Calls for Withdrawal of Ranitidine Products as Review Finds Contaminant Could Pose Riskhttps://modernod.com/news/fda-calls-for-withdrawal-of-ranitidine-products-as-review-finds-contaminant-could-pose-risk/2477519/The FDA requested that manufacturers immediately pull all prescription and over-the-counter (OTC) ranitidine drugs from the market, saying new evidence indicates users could be exposed to “unacceptable levels” of the probable carcinogen N-nitrosodimethylamine (NDMA) over time under ce
- Nicox to Present NCX 470 Phase 2 Results at Glaucoma 360 New Horizons Forumhttps://modernod.com/news/nicox-to-present-ncx-470-phase-2-results-at-glaucoma-360-new-horizons-forum/2477281/Nicox SA today announced that Tomas Navratil, PhD, Executive Vice President, Head of R&D of Nicox group, and General Manager of Nicox Ophthalmics, Inc, will present results from the NCX 470 Dolomites phase 2 clinical trial in the session “New Horizons in Pharmaceuticals” at the Glaucoma 360 N
- Alcon to Hold Second Annual Alcon Retina Fellows Institutehttps://modernod.com/news/alcon-to-hold-second-annual-alcon-retina-fellows-institute/2477120/Alcon announced it will host future ophthalmology leaders for the second annual Alcon Retina Fellows Institute, an educational experience where first year retina fellows gain hands-on surgical training and mentorship from some of the leading ophthalmologists in the field, according to a company n
- Adverum Biotechnologies Doses First Patient in Third Cohort of OPTIC Clinical Trial of Intravitreal Gene Therapy for Wet AMDhttps://modernod.com/news/adverum-biotechnologies-doses-first-patient-in-third-cohort-of-optic-phase-1-clinical-trial-of-advm-022-intravitreal-gene-therapy-for-wet-amd/2477039/Adverum Biotechnologies announced that the first patient was dosed in the third cohort (n=9) of the ongoing OPTIC phase 1 clinical trial for ADVM-022 for the treatment of neovascular age-related macular degeneration (AMD). Patients in this cohort are receiving a single intravitreal injection of g
- Hillrom Introduces Next-Generation Technology In Fight Against Diabetic Retinopathyhttps://modernod.com/news/hillrom-introduces-next-generation-technology-in-fight-against-diabetic-retinopathy/2476777/Hillrom announced its latest innovation in vision screening and diagnostics with the introduction of the Welch Allyn RetinaVue 700 Imager handheld retinal camera, which enables remote ophthalmologists to diagnose diabetic retinopathy during routine primary care office visits. “Our n
- Nicox Receives $3 Million Milestone Payment From Eyevance for Zerviate in the UShttps://modernod.com/news/nicox-receives-3-million-milestone-payment-from-eyevance-for-zerviate-in-the-us/2479567/Nicox SA announced that it has received a $3 million milestone payment from partner Eyevance Pharmaceuticals after completion of the regulatory and manufacturing activities. Nicox and Eyevance entered into a licensing agreement for Zerviate in the United States in September 2017 in which N
- Santen Launches Verkazia for Children and Adolescents with Severe Allergic Eye Conditionhttps://modernod.com/news/santen-launches-verkazia-for-children-and-adolescents-with-severe-allergic-eye-condition/2479744/Santen UK announced the launch of Verkazia eye drops emulsion containing 0.1% (1mg/ml) ciclosporin for the treatment of the rare disease severe vernal keratoconjunctivitis (VKC) in children from 4 years of age and adolescents. Verkazia, which has been granted orphan drug status, provides a much-n
- Oculus to Present New Formulas for the Pentacam AXLhttps://modernod.com/news/oculus-to-present-new-formulas-for-the-pentacam-axl-advanced-barrett-and-olsen-formulas/2479866/At the ESCRS 2018 in Vienna, Oculus is introducing the advanced Barrett Toric calculator, including the posterior cornea, and the Olsen ray-tracing formula, within the IOL calculator of the Pentacam AXL. Both formulas are available to all Pentacam AXL users in a free software update. The n
- Horizon Surgical Systems Announces World’s First Robotic Cataract Surgery Using the Polaris Platformhttps://modernod.com/news/horizon-surgical-systems-announces-worlds-first-robotic-cataract-surgery-using-the-polaris-platform/2484160/Horizon Surgical Systems announced the completion of the world’s first cataract surgery performed using its Polaris robotic platform. The milestone procedure was conducted by Uday Devgan, MD, FACS.
- New Study on AI-Driven Solutions for Diabetic Eye Disease Testing in Underserved Populations Publishedhttps://modernod.com/news/new-study-on-ai-driven-solutions-for-diabetic-eye-disease-testing-in-underserved-populations-published/2482441/Michael D. Abramoff, MD, PhD, founder and executive chairman of Digital Diagnostics, and the creator of the LumineticsCore AI system for diagnosing diabetic retinopathy, has co-authored a study exploring the potential of autono